March 28, 2017
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Speaker reviews factors that impact response to treatment for Crohn’s disease, ulcerative colitis
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK — At the Interdisciplinary Autoimmune Summit, Steven B. Hanauer, MD, medical director of the Digestive Health Center at Northwestern University, Feinberg School of Medicine, talked about his presentation on strategies in the management of inflammatory bowel disease.
He mentioned that patients who have a with good prognosis have mild inflammation within the gut; whereas patients who have a bad prognosis present at early age, have extensive disease and have extra-intestinal manifestations. In addition, patients who smoke have a bad prognosis in Crohn’s disease.